OVERVIEW

Cataract Surgery: Discussions on Post-Operative Ocular Inflammation is organized by Evolve Medical Education (EME) LLC.

Release Date: June 29, 2020
Expiration Date: Wednesday, June 15, 2023

Description:
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.

All education activities identified in this education design document will be targeted at ophthalmologists and optometrists. The following categories of doctors have been identified as those with the greatest need for this educational intervention:
I. Ophthalmologists who perform ophthalmic surgery.
II. Ophthalmologists involved in the management of ocular inflammation following ophthalmic surgery.
III. Optometrists who comanage patients following cataract surgery.

Learning Objectives:
At the completion of this educational activity, you will be better able to:
• Compare the drug delivery properties of novel sustained-release medications.
• Identify the issues surrounding patient adherence and compliance with topical medications after ocular surgery.
• Interpret and explain to patients the latest available treatments and determine which option is best for each patient.
• Describe how federal regulations on reimbursement affect practices as well as patients being treated for pain and inflammation associated with ophthalmic surgery.

Additional details will be posted as soon as information is available.